Description
Azacitidine Injection is a prescription medication used primarily for the treatment of myelodysplastic syndromes (MDS).
- Key features of Azacitidine Injection: Antineoplastic Agent: Effectively classified as a chemotherapy drug thatdisrupts abnormal cells growth.
- Subcutaneous Administration: Designed for subcutaneous injection, providing ease of administration without the need for complex infusion procedures.
- Dosage Adjustability: Dose management tailored by healthcareprofessionals based on individual patient requirements and response.
- Therapeutic Benefits: Aides in the treatment of certain types of blooddisorders by promoting normal maturation of blood cells, lowering the need for supportive care.
- Proven Efficacy: Clinically validated in several studies for improvingpatient quality of life through reduction in symptoms and lowering reliance on blood transfusions.
